152 related articles for article (PubMed ID: 6775960)
1. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids.
Maton PN; Ellis HJ; Higgins MJ; Dowling RH
Eur J Clin Invest; 1980 Aug; 10(4):325-32. PubMed ID: 6775960
[TBL] [Abstract][Full Text] [Related]
2. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels.
Angelin B; Ewerth S; Einarsson K
J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153
[TBL] [Abstract][Full Text] [Related]
5. Early morphologic and enzymatic changes in livers of rats treated with chenodeoxycholic and ursodeoxycholic acids.
Shefer S; Zaki FG; Salen G
Hepatology; 1983; 3(2):201-8. PubMed ID: 6832710
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment.
Sahlin S; Ahlberg J; Reihnér E; Ståhlberg D; Einarsson K
Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340
[TBL] [Abstract][Full Text] [Related]
7. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH
Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304
[TBL] [Abstract][Full Text] [Related]
8. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
[TBL] [Abstract][Full Text] [Related]
9. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol gallstone formation and prevention by chenodeoxycholic and ursodeoxycholic acids. A new hamster model.
Pearlman BJ; Bonorris GG; Phillips MJ; Chung A; Vimadalal S; Marks JW; Schoenfield LJ
Gastroenterology; 1979 Oct; 77(4 Pt 1):634-41. PubMed ID: 467920
[TBL] [Abstract][Full Text] [Related]
11. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
von Bergmann K; Epple-Gutsfeld M; Leiss O
Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
[TBL] [Abstract][Full Text] [Related]
12. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
[TBL] [Abstract][Full Text] [Related]
15. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid treatment of gallstones. Dose-response study and possible mechanism of action.
Maton PN; Murphy GM; Dowling RH
Lancet; 1977 Dec 24-31; 2(8052-8053):1297-301. PubMed ID: 74722
[TBL] [Abstract][Full Text] [Related]
18. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity.
Reihnér E; Björkhem I; Angelin B; Ewerth S; Einarsson K
Gastroenterology; 1989 Dec; 97(6):1498-505. PubMed ID: 2583415
[TBL] [Abstract][Full Text] [Related]
19. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
[TBL] [Abstract][Full Text] [Related]
20. Alteration of biliary ursodeoxycholic acid in guinea pig during early stages of cholestyramine feeding.
Li JR; Dinh DM; Kottke BA
Steroids; 1979; 34(6 Spec no):705-15. PubMed ID: 538776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
